BP
GEHC icon

Ballentine Partners’s GE HealthCare GEHC Stock Holding History

Ballentine Partners’s Portfolio GEHC Stock Details GEHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-8,449
Closed -$601K – 1099
2026
Q1 		$601K Buy
8,449
+5,459
+183% +$430K 0.01% 469
2025
Q4 		$245K Buy
2,990
+269
+10% +$21K ﹤0.01% 823
2025
Q3 		$204K Sell
2,721
-1,871
-41% -$140K ﹤0.01% 908
2025
Q2 		$340K Sell
4,592
-2,405
-34% -$167K 0.01% 638
2025
Q1 		$565K Buy
6,997
+49
+0.7% +$4.21K 0.01% 411
2024
Q4 		$543K Sell
6,948
-241
-3% -$20.5K 0.01% 405
2024
Q3 		$675K Buy
7,189
+559
+8% +$46.9K 0.01% 353
2024
Q2 		$517K Buy
6,630
+204
+3% +$16.6K 0.01% 401
2024
Q1 		$584K Buy
6,426
+199
+3% +$16.6K 0.01% 360
2023
Q4 		$481K Buy
6,227
+1,932
+45% +$135K 0.01% 373
2023
Q3 		$292K Sell
4,295
-459
-10% -$33.4K 0.01% 451
2023
Q2 		$386K Buy
4,754
+100
+2% +$7.98K 0.01% 380
2023
Q1 		$382K Buy
+4,654
New +$332K 0.01% 360

Other funds holding GEHC

RRAM
River Road Asset Management Louisville, Kentucky $8.99B AUM 12.83% 1-Year Est. Return
PL
Perpetual Ltd Sydney, New South Wales, Australia $7B AUM 19.75% 1-Year Est. Return
WCM
Wedge Capital Management Charlotte, North Carolina $6.06B AUM 47.24% 1-Year Est. Return
DLA
Douglas Lane & Associates New York $7.37B AUM 21.9% 1-Year Est. Return
AOI
Auto-Owners Insurance Lansing, Michigan $4.43B AUM 30.05% 1-Year Est. Return
GA
GuoLine Advisory Singapore $1.07B AUM 26.27% 1-Year Est. Return
Mirae Asset Global Investments
Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return
NCM
Northside Capital Management Hood River, Oregon $1.22B AUM 20.77% 1-Year Est. Return
Handelsbanken Fonder
Handelsbanken Fonder Stockholm, Sweden $35.1B AUM 47.76% 1-Year Est. Return
SIC
Salem Investment Counselors Winston Salem, North Carolina $4.03B AUM 61.49% 1-Year Est. Return

Ballentine Partners's GEHC Position: Q2 2026 in Review

Ballentine Partners sold out of GE HealthCare (GEHC) in Q2 2026, closing a stake of 8,449 shares — an estimated $601K sold.

Ballentine Partners first reported a position in GEHC in Q1 2023 and held it in 13 quarters. The position peaked at $675K in Q3 2024. 269 funds tracked by Wall St. Rank hold GEHC as of Q2 2026.

  • Ballentine Partners reported no remaining GE HealthCare position as of Q2 2026 after selling out during the quarter.
  • Ballentine Partners sold 8,449 GE HealthCare shares in Q2 2026, an estimated $601K.
  • Ballentine Partners first reported a position in GE HealthCare in Q1 2023 and held it in 13 quarters.
  • Ballentine Partners's GE HealthCare position peaked at $675K in Q3 2024.
  • 269 funds tracked by Wall St. Rank held GE HealthCare as of Q2 2026.

Based on Ballentine Partners's 13F filing for Q2 2026, filed 17 Jul 2026.